ms AMANDA MOTT

S.1145, The Patent Reform Act of 2007, Potenital implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Intellectual property provisions of Free-Trade Agreements and otherwise as part of US trade policy HR 1432, HR 1902 - Patent Settlement Bills re: prohibition of brand name manufacturers compensating generic manufacturers for delay of generic entry to market HR 5629, Pathway for Biosimilars Act, U.S. House - legislation regarding patent protection of biological products re: generic/follow-on biologic products

S.1145, The Patent Reform Act of 2007, Potenital implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Intellectual property provisions of Free-Trade Agreements and otherwise as part of US trade policy HR 1432, HR 1902 - Patent Settlement Bills re: prohibition of brand name manufacturers compensating generic manufacturers for delay of generic entry to market HR 5629, H.R. 1956, H.R. 1038, S. 1695 Pathway for Biosimilars Act, U.S. House - legislation regarding patent protection of biological products re: generic/follow-on biologic products

S.1145, The Patent Reform Act of 2007, Potenital implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Intellectual property provisions of Free-Trade Agreements and otherwise as part of US trade policy HR 1432, HR 1902 - Patent Settlement Bills re: prohibition of brand name manufacturers compensating generic manufacturers for delay of generic entry to market HR 5629, Pathway for Biosimilars Act, U.S. House - legislation regarding patent protection of biological products re: generic/follow-on biologic products

S.1145, The Patent Reform Act of 2007, Potential implications of pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries HR 5629, Pathway for Biosimilars Act Intellectual property provisions of free-trade agreements and otherwise as part of US trade policy

S.1145, The Patent Reform Act of 2007, Potenital implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Intellectual property provisions of Free-Trade Agreements and otherwise as part of US trade policy HR 1432, HR 1902 - Patent Settlement Bills re: prohibition of brand name manufacturers compensating generic manufacturers for delay of generic entry to market HR 5629, H.R. 1956, H.R. 1038, S. 1695 Pathway for Biosimilars Act, U.S. House - legislation regarding patent protection of biological products re: generic/follow-on biologic products

Medcaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act S.3118-The Preserving Access to Medicare Act Waxman proposal for Medicaid-type rebates for dual elibigles enrolled in Medicare Part D. No active legislation-US House Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D Anti-Preemption Medicare Part D-US House

Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D

Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package

Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D

S.1145, The Patent Reform Act of 2007, Potenital implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Intellectual property provisions of Free-Trade Agreements and otherwise as part of US trade policy HR 1432, HR 1902 - Patent Settlement Bills re: prohibition of brand name manufacturers compensating generic manufacturers for delay of generic entry to market HR 5629, H.R. 1956, H.R. 1038, S. 1695 Pathway for Biosimilars Act, U.S. House - legislation regarding patent protection of biological products re: generic/follow-on biologic products

S.1145, The Patent Reform Act of 2007, Potential implications of pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries HR 5629, Pathway for Biosimilars Act Intellectual property provisions of free-trade agreements and otherwise as part of US trade policy

S.1145, The Patent Reform Act of 2007, Potenital implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Intellectual property provisions of Free-Trade Agreements and otherwise as part of US trade policy HR 1432, HR 1902 - Patent Settlement Bills re: prohibition of brand name manufacturers compensating generic manufacturers for delay of generic entry to market HR 5629, Pathway for Biosimilars Act, U.S. House - legislation regarding patent protection of biological products re: generic/follow-on biologic products

S.1145, The Patent Reform Act of 2007, Potenital implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Intellectual property provisions of Free-Trade Agreements and otherwise as part of US trade policy HR 1432, HR 1902 - Patent Settlement Bills re: prohibition of brand name manufacturers compensating generic manufacturers for delay of generic entry to market HR 5629, H.R. 1956, H.R. 1038, S. 1695 Pathway for Biosimilars Act, U.S. House - legislation regarding patent protection of biological products re: generic/follow-on biologic products

S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage S.2029 - Physician Payments Sunshine Act of 2007; Grassley/Kohl Bill - regarding proposal to require pharmaceutical manufacturers to disclose provision of items of value to physicians on an annual basis DoD Tricare issues, including retail pharmacy rebate and other issues Comparative Effectivensss - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Genetic Information Nondiscrimination Act Information regarding company patient assistance program Health care reform Legislation to fund cancer research, cancer supportive services and improve access to coverage 340B program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services

Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D

Medcaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act S.3118-The Preserving Access to Medicare Act Waxman proposal for Medicaid-type rebates for dual elibigles enrolled in Medicare Part D. No active legislation-US House Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D Anti-Preemption Medicare Part D-US House

Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D

Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package

Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D

Medcaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act S.3118-The Preserving Access to Medicare Act Waxman proposal for Medicaid-type rebates for dual elibigles enrolled in Medicare Part D. No active legislation-US House Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D Anti-Preemption Medicare Part D-US House

Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D

Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package

S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services

S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services

S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.

S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation

S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation

S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services

S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage S.2029 - Physician Payments Sunshine Act of 2007; Grassley/Kohl Bill - regarding proposal to require pharmaceutical manufacturers to disclose provision of items of value to physicians on an annual basis DoD Tricare issues, including retail pharmacy rebate and other issues Comparative Effectivensss - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Genetic Information Nondiscrimination Act Information regarding company patient assistance program Health care reform Legislation to fund cancer research, cancer supportive services and improve access to coverage 340B program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services

S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.

S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation

S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation

S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services

S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation

S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.

S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation

S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007

S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007

S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007

S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007

S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007

S.1082-Food and Drug Administration Revitalization Act of 2007 H.R. 2900 Food and Drug Administration Amendments Act of 2007 Illegal Pharmaceutical Manufacturing S.1859 Agriculture Appropriations - Title VI: Food and Drug Administration

S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA

S.5 & H.R. 3 - Stem Cell Research Enhancement Act of 2007

S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA

Drug Importation Issues S.A. 1010 - Safety and Cost Savings Certification re: Importation of Pharmaceuticals S. 242 & H.R.380 - Pharmaceutical Market Access and Drug Safety Act of 2007 Safe Drug Compounding Act of 2007 (draft legislation - no bill number)

S.3 - Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 Medicaid Rebate Rate

S.1145/1908 The Patent Reform Act of 2007 - Potential implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries

S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007

H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007

S.1082-Food and Drug Administration Revitalization Act of 2007 H.R. 2900 Food and Drug Administration Amendments Act of 2007 Illegal Pharmaceutical Manufacturing S.1859 Agriculture Appropriations - Title VI: Food and Drug Administration

S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA

H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007

Drug Importation Issues S.A. 1010 - Safety and Cost Savings Certification re: Importation of Pharmaceuticals S. 242 & H.R.380 - Pharmaceutical Market Access and Drug Safety Act of 2007 Safe Drug Compounding Act of 2007 (draft legislation - no bill number)

S.3 - Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 Medicaid Rebate Rate

S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007

S.5 & H.R. 3 - Stem Cell Research Enhancement Act of 2007

H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007

H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007